News

• Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
  13:00 - GlobeNewswire
•  
• ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution
  09/22/2020 / 16:55 - GlobeNewswire
•  
• CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease
  09/22/2020 / 15:00 - GlobeNewswire
•  
• Reminder: ViralClear to Host Conference Call and Webcast on September 22, 2020 to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19
  09/21/2020 / 17:01 - GlobeNewswire
•  
• Colorescience® Announces Successful Completion of $30 Million Debt Financing
  09/14/2020 / 13:00 - GlobeNewswire
•  
• ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19
  09/09/2020 / 18:16 - GlobeNewswire
•  
• GBT and Sickle Cell Disease Association of America to Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference
  09/09/2020 / 14:00 - GlobeNewswire
•  
• CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference
  09/03/2020 / 14:00 - GlobeNewswire
•  
• Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
  08/31/2020 / 14:00 - GlobeNewswire
•  
• Mersana Therapeutics Appoints Chuck Miller as Senior Vice President of Regulatory Affairs
  08/31/2020 / 14:00 - GlobeNewswire
•  
• Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
  08/25/2020 / 22:01 - GlobeNewswire
•  
• BioSig Technologies to Present at The LD 500 Virtual Conference
  08/25/2020 / 14:30 - GlobeNewswire
•  
• Atea Pharmaceuticals Strengthens Management Team with Appointment of Clinical and Regulatory Leadership
  08/24/2020 / 12:00 - GlobeNewswire
•  
• Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
  08/10/2020 / 13:00 - GlobeNewswire
•  
• Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClear’s Scientific Advisory Board
  08/06/2020 / 16:00 - GlobeNewswire